The delta-globin RNA transcript level in beta-thalassemia carriers

Acta Haematologica

Volumn 102, Issue 1, 1999, Pages 1-6

  Huang, Shu Zhen ^a,b   Zeng, Fan Yi ^a,b   Chen, Mei Jue ^a   Ren, Zhao Rui ^a   Shen, Min ^a   Rodgers, Griffin P ^b   Schechter, Alan N ^b   Zeng, Yi Tao ^a  

^a SHANGHAI CHILDREN S HOSPITAL   (China)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

thalassemia; globin gene; HbA2; Heterozygote; mRNA

Indexed keywords

DELTA GLOBIN; HEMOGLOBIN A2; MESSENGER RNA;

ALLELE; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HETEROZYGOTE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RETICULOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

ASIAN CONTINENTAL ANCESTRY GROUP; BETA-THALASSEMIA; CHILD; CODON; GLOBINS; HETEROZYGOTE DETECTION; HUMANS; LINEAR MODELS; MUTATION; RETICULOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032873983     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040959     Document Type: Article

References (19)

1. Kunkle HG, Wallenius G: New hemoglobin in normal human blood. Science 1955;122:288.
2. Kunkle HG, Ceppellini R, Muller-Eberhard U, Wolf J: Observations on the minor basic hemoglobin component in the blood of normal individuals and patients with thalassemia. J Clin Invest 1957;36:1615-1625.
3. Weatherall DJ, Clegg JB: The Thalassemia Syndromes. Oxford, Blackwell Scientific Publications, 1981.
4. 2 in patients with different β-thalassemia mutations and a β-variant. Blood 1990;76:1246-1249.
5. 2: Origin, evolution, and aftermath. Blood 1991; 78:2165-2177.
6. Singer K, Chernoff AI, Singer L: Studies of abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation. Blood 1951;6:413-428.
7. Huang SZ, Zeng YT, Chen MJ, Shen Min: Determination of the reference range of hemoglobin in 520 healthy people residing in Shanghai City. Shanghai Med J 1980;3:468-471.
8. Huang SZ, Zhou XD, Zhu H, Ren ZR, Zeng YT: Detection of β-thalassemia mutations in the Chinese using amplified DNA from dried blood specimens. Hum Genet 1990;84:129-131.
9. Huang SZ, Rodgers GP, Zeng FY, Schechter AN: Diagnosis of thalassemia using cDNA amplification of circulating erythroid cell mRNA with the polymerase chain reaction. Blood 1991;78:2433-2437.
10. Huang SZ, Zeng FY, Ren ZR, Lu ZH, Rodgers GP, Schechter AN, Zeng YT: RNA transcripts of β-thalassemia allele 1VS-2-654 C→T: A small amount of normally processed β-globin mRNA is still produced from the mutant gene. Br J Haematol 1994;88:541-546.
11. Kutlar A, Kutlar F, Gu LG, Mayson SM, Huisman THJ: Fetal hemoglobin in normal adults and β-thalassemia heterozygotes. Hum Genet 1990;85:106-110.
12. +-thalassemia. Br J Haematol 1990;75:122-126.
13. Gonzalez-Redondo JM, Stoming TA, Kutlar A, Kutlar F, Lanclos KD, Howard EF, Fei YJ, Aksoy M, Altay C, Gurgey A, Basak AN, Efremov GD, Petkov G, Huisman THJ: A C→T substitution at nt-101 in a conserved DNA sequence of the promotor region of the β-globin gene is associated with 'silent' β-thalassemia. Blood 1989;73:1705-1711.
14. Huisman THJ: Levels of HbA2 in heterozygotes and homozygotes for β-thalassemia mutation: Influence of mutation in the CACCC and ATAAA motifs of the β-globin gene promoter. Acta Haematol 1998;90:187-194.
15. Bunn HF, Forget BG: Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, Saunders, 1986.
16. Rund D, Filon D, Strauss N, Rachmilewitz E, Oppenheim A: Mean corpuscular volume of heterozygotes for β-thalassemia correlates with the severity of mutation. Blood 1992;79:238-243.
17. Efremov DG, Dimovski AJ, Sukarova E, Schiliro G, Zisovski N, Efremov GD, Burrone OR, Huisman THJ: γ-mRNA and HbF levels in β-thalassemia. Br J Haematol 1994;88:311-317.
18. Orkin SH: Globin gene regulation and switching. Cell 1990;63:820-825.
19. Berg PE, Schechter AN: The impact of molecular biology on the diagnosis and treatment of hemoglobin disorders. Mol Genet Med 1993;2: 1-38.